About Biome Diagnostics

Biome Diagnostics is dedicated to advancing precision medicine in the area of cancer detection and treatment through breakthrough microbiome-based products. With BiomeOne®, the company has developed an immune profiler predicting the response and immune-related adverse events of cancer immunotherapy based on the gut microbiome. The test allows oncologists to administer the most effective first-line treatment and improve therapy response of patients. BiomeOne® has been validated in a multi-centricView more